Clinical Trial Update: A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing adverse events and effectiveness of upadacitinib oral tablets in adults and adolescents with vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Vitiligo | Phase 3 | Status: ACTIVE_NOT_RECRUITING